Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study

Research output: Contribution to journalJournal articlepeer-review


  1. Neural Substrates of Psychotic Depression: Findings From the Global ECT-MRI Research Collaboration

    Research output: Contribution to journalJournal articlepeer-review

  2. A Nationwide Cohort Study of Nonrandom Mating in Schizophrenia and Bipolar Disorder

    Research output: Contribution to journalJournal articlepeer-review

  1. Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol

    Research output: Contribution to journalJournal articlepeer-review

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Research output: Contribution to journalJournal articlepeer-review

  3. Dyslipidaemia in patients with mental illness

    Research output: Contribution to journalJournal articlepeer-review

  • Paola Dazzan
  • Andrew J Lawrence
  • Antje A T S Reinders
  • Alice Egerton
  • Neeltje E M van Haren
  • Kate Merritt
  • Gareth J Barker
  • Rocio Perez-Iglesias
  • Kyra-Verena Sendt
  • Arsime Demjaha
  • Kie W Nam
  • Iris E Sommer
  • Christos Pantelis
  • W Wolfgang Fleischhacker
  • Inge Winter van Rossum
  • Silvana Galderisi
  • Armida Mucci
  • Richard Drake
  • Shon Lewis
  • Mark Weiser
  • Covadonga M Martinez Diaz-Caneja
  • Joost Janssen
  • Marina Diaz-Marsa
  • Roberto Rodríguez-Jimenez
  • Celso Arango
  • Lone Baandrup
  • Brian Broberg
  • Egill Rostrup
  • Bjørn H Ebdrup
  • Birte Glenthøj
  • Rene S Kahn
  • Philip McGuire
  • OPTiMiSE study group
View graph of relations

Individuals with psychoses have brain alterations, particularly in frontal and temporal cortices, that may be particularly prominent, already at illness onset, in those more likely to have poorer symptom remission following treatment with the first antipsychotic. The identification of strong neuroanatomical markers of symptom remission could thus facilitate stratification and individualized treatment of patients with schizophrenia. We used magnetic resonance imaging at baseline to examine brain regional and network correlates of subsequent symptomatic remission in 167 medication-naïve or minimally treated patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder entering a three-phase trial, at seven sites. Patients in remission at the end of each phase were randomized to treatment as usual, with or without an adjunctive psycho-social intervention for medication adherence. The final follow-up visit was at 74 weeks. A total of 108 patients (70%) were in remission at Week 4, 85 (55%) at Week 22, and 97 (63%) at Week 74. We found no baseline regional differences in volumes, cortical thickness, surface area, or local gyrification between patients who did or did not achieved remission at any time point. However, patients not in remission at Week 74, at baseline showed reduced structural connectivity across frontal, anterior cingulate, and insular cortices. A similar pattern was evident in patients not in remission at Week 4 and Week 22, although not significantly. Lack of symptom remission in first-episode psychosis is not associated with regional brain alterations at illness onset. Instead, when the illness becomes a stable entity, its association with the altered organization of cortical gyrification becomes more defined.

Original languageEnglish
JournalSchizophrenia Bulletin
Issue number2
Pages (from-to)444-455
Number of pages12
Publication statusPublished - 16 Mar 2021

    Research areas

  • cortical thickness, first episode, gyrification, MRI, OPTiMiSE, schizophrenia, trial

ID: 61059352